TEVA PHARMACEUTICAL INDUSTRIES LTD
NYSE · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Teva Pharmaceutical Industries develops, manufactures, and sells generic and branded pharmaceuticals, including treatments for conditions such as multiple sclerosis, migraine, and Parkinson's disease, as well as active pharmaceutical ingredients and biosimilars sold worldwide.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Sabag MarkSee "Remarks" | Sell | $1.93M | 46,000at $41.93 | Nov 5, 2026 |
| Bergwerk DovInterim Cheif Legal Officer | Sell | $730K | 17,505at $41.72 | Nov 4, 2026 |
| Bergwerk DovInterim Cheif Legal Officer | Sell | $365K | 8,755at $41.72 | Nov 4, 2026 |
| Savage BrianInterim Chief Legal Officer | Sell | $174K | 4,503at $38.69 | Sep 18, 2026 |
| Savage BrianInterim Chief Legal Officer | Sell | $99K | 2,525at $39.15 | Sep 18, 2026 |
| Savage BrianInterim Chief Legal Officer | Sell | $12K | 314at $38.70 | Sep 18, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Alan ArmstrongArmstrong, Alan (Senator) | Senate | Buy | $1,001 - $15,000 | Mar 30, 2026 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable TEVA activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.